TriVascular Technologies (TRIV) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
TriVascular Technologies, Inc. Reports Third Quarter Financial Results
November 9, 2015 4:01 PM ESTSANTA ROSA, Calif., Nov. 9, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ: TRIV), manufacturer of the Ovation® Abdominal Stent Graft platform, today reported financial results for the third quarter ended September 30, 2015.
Recent Accomplishments:
Third quarter revenue of $9.5 million, up 20.0% over the third quarter of 2014 as reported, and 23.4% on a constant currency basis Third quarter gross margin of 63.5%, an increase from 57.2% in the third quarter of 2014 4-year Ovation Clinical data presented at the November VIVA conference Interim LIFE Study data highlighting clinical & economic benefits of Ovation platform... More